top of page
Report Summary
Market Overview

Global Companion Animal Vaccines Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)

Global Companion Animal Vaccines Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)


Market Segmentation: By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Other Technologies), Animal Type (Dogs, Cats, and Other Animal Types), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Market Overview


The Global Companion Animal Vaccines Market was valued at USD 3,334.0 million in 2023 and is expected to reach USD 5,362.2 million by 2031 while growing at a CAGR of 6.1% during the forecast period (2024-2031).

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Market Dynamics


This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global companion animal vaccines market growth. Companion animal vaccines are biologics crafted to elicit an immune response in pets like dogs and cats, crucial in preventing and controlling infectious diseases that impact their health. These vaccines, akin to human vaccines, are Animal Typeed to grant immunity against specific pathogens, including viruses and bacteria.


Increasing awareness of zoonotic diseases and advancements in vaccine technology are expected to drive significant growth in the Companion Animal Vaccines market. Despite this potential, market expansion may encounter challenges such as stringent regulatory requirements, approval processes, and a lack of awareness among pet owners and veterinarians.


Furthermore, the global companion animal vaccines industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.


Segmentation – By Technology Analysis


The Global Companion Animal Vaccines Market is segmented among Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Other Technologies, based on Technology. In 2023, Live Attenuated Vaccines accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Segmentation – By Animal Type Analysis


The Global Companion Animal Vaccines Market is segmented among Dogs, Cats, and Other Animal Types, based on Animal Type. In 2023, Dogs accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Global Companion Animal Vaccines Market: Regional Analysis


Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Competitive Landscape


Some of the key players operating in the market are Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Brilliant Bio Pharma, Merck & Co. Inc., Virbac, Zoetis Inc., Indian Immunologicals Ltd, Bioveta AS, Durvet Inc., and HIPRA.


 Table of Contents:


1. Research Methodology and Market Scope

  • Research Methodology

  • Market Scope

2. Executive Summary

3. Global Companion Animal Vaccines Market Dynamics

  • Drivers

  • Restraints

  • Opportunity

4. Global Companion Animal Vaccines Industry Analysis

  • PEST Analysis

  • Porter's Five Force Analysis

  • Recent Deals Analysis

5. Global Companion Animal Vaccines Market Segmentation, By Technology

  • Global Companion Animal Vaccines Market Share Analysis, By Technology

  • Global Companion Animal Vaccines Market Growth Analysis, By Technology

  • Global Companion Animal Vaccines Market Trends, By Technology

o Live Attenuated Vaccines

o Inactivated Vaccines

o Toxoid Vaccines

o Recombinant Vaccines

o Other Technologies

6. Global Companion Animal Vaccines Market Segmentation, By Animal Type

  • Global Companion Animal Vaccines Market Share Analysis, By Animal Type

  • Global Companion Animal Vaccines Market Growth Analysis, By Animal Type

  • Global Companion Animal Vaccines Market Trends, By Animal Type

o Dogs

o Cats

o Other Animal Types

7. Global Companion Animal Vaccines Market Segmentation, By Region

  • Global Companion Animal Vaccines Market Share Analysis, By Region

  • Global Companion Animal Vaccines Market Growth Analysis, By Region

  • Global Companion Animal Vaccines Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

  • Elanco Animal Health Incorporated*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

  • Boehringer Ingelheim GmbH

  • Brilliant Bio Pharma

  • Merck & Co. Inc.

  • Virbac

  • Zoetis Inc.

  • Bioveta AS

  • Durvet Inc.

  • HIPRA

 *Similar analysis will be provided for each company listed above.

REPORT.png
Pricing Plan
Segmentation
Regional Analysis
Table of Contents
bottom of page